RE:how do you say,What can they prove? Well they can prove that a relatively small Phase 3 cancer trial provided a 20% or higher complete response rate, in a difficult to treat population, with few safety issues. That is all they can prove. If this were US based company that just had an FDA review of a recently completed P3 with the same results, and the FDA said, "we like it, and could almost approve on this alone but need another P3" what would it be worth? I think a f--k of a lot more than 20 mil. I think that could be assumed to be proveable as well. Should be enough there to sell